Zhuang Sun1, Justin L Quon2, Charles D Papageorgiou2, Brahim Benyahia1, Chris D Rielly1. 1. Future Continuous Manufacturing and Advanced Crystallization (CMAC), Research Hub at the Department of Chemical Engineering, Loughborough University, Loughborough, Leicestershire LE11 3TU, United Kingdom. 2. Process Chemistry and Development, Takeda Pharmaceuticals International Company, 40 Landsdowne Street, Cambridge, Massachusetts 02139, United States.
Abstract
The objective of the research was to improve the process design of a combined antisolvent-cooling crystallization to reduce the degree of agglomeration of a real active pharmaceutical ingredient product, which was manufactured using a crystallization stage employing a methanol/water solvent system. Knowledge was gained from the use of process analytical technology (PAT) tools to monitor the process variables, allowing particle size, degree of agglomeration, solute concentration, and supersaturation to be tracked throughout the process. Based on knowledge of the solubility behavior and interpretation of the PAT histories, changes were made to the sequences of antisolvent addition and cooling within the crystallization process to reduce agglomeration in the final product. Different seed loadings and seeding addition points were also investigated to maintain operation within lower supersaturation regions of the phase diagram to limit agglomeration and avoid an undesired polymorphic transformation to an unstable form. The improved sequences of operations and seeding conditions did not provide sufficient improvement in the product quality and so were augmented by applying wet milling for further deagglomeration followed by temperature cycling to remove fine particles generated during milling. Open-loop heating and cooling cycles produced some limited improvements, whereas closed-loop direct nucleation control methods using FBRM as a feedback sensor for particle counts per second were much more successful at producing high-quality crystals of the desired polymorphic form. The work shows that understanding the trajectory of the process through the phase diagram to follow appropriate supersaturation profiles gives improved control of the various kinetic mechanisms and can be used to improve the quality of the final product.
The objective of the research was to improve the process design of a combined antisolvent-cooling crystallization to reduce the degree of agglomeration of a real active pharmaceutical ingredient product, which was manufactured using a crystallization stage employing a methanol/water solvent system. Knowledge was gained from the use of process analytical technology (PAT) tools to monitor the process variables, allowing particle size, degree of agglomeration, solute concentration, and supersaturation to be tracked throughout the process. Based on knowledge of the solubility behavior and interpretation of the PAT histories, changes were made to the sequences of antisolvent addition and cooling within the crystallization process to reduce agglomeration in the final product. Different seed loadings and seeding addition points were also investigated to maintain operation within lower supersaturation regions of the phase diagram to limit agglomeration and avoid an undesired polymorphic transformation to an unstable form. The improved sequences of operations and seeding conditions did not provide sufficient improvement in the product quality and so were augmented by applying wet milling for further deagglomeration followed by temperature cycling to remove fine particles generated during milling. Open-loop heating and cooling cycles produced some limited improvements, whereas closed-loop direct nucleation control methods using FBRM as a feedback sensor for particle counts per second were much more successful at producing high-quality crystals of the desired polymorphic form. The work shows that understanding the trajectory of the process through the phase diagram to follow appropriate supersaturation profiles gives improved control of the various kinetic mechanisms and can be used to improve the quality of the final product.
Crystallization is a unit
operation widely applied in the pharmaceutical,
fine chemical, and food industries for the purification and control
of product characteristics, such as crystal size and shape.[1] Generally, the workflow for designing a crystallization
process consists of five steps: (1) assessment of product chemical
and physical information, (2) solvent screening and selection, (3)
selection and calibration of process analytical technology (PAT) tools,
(4) system and process understanding, and (5) design and proof of
concept demonstration of the crystallization.[2] In this work, the design of a batch sequential antisolvent and cooling
crystallization of a Takeda API (compound X) was investigated experimentally
by adapting the workflow proposed by Brown et al.[2] During the initial process development, which predates
Brown et al.,[2] a solvent screen had been
conducted by Takeda, and to avoid oiling out of the product, a methanol
and water mixture was selected. The baseline process for the crystallization
was to add seeds to a saturated solution with 10/1 (v/v) of methanol:water at55 °C followed by antisolvent
(water) until reaching 10/6 (v/v) and finally cooling from 55 to 20 °C. The problem to be solved
was that the isolated product was found to be heavily agglomerated,
which increased the chance of impurity entrapment and could impact
drug product manufacturability and performance.[3]Thus, the purpose of the research described in this
manuscript
was to design an improved crystallization process to reduce the extent
of agglomeration and obtain crystals with a regular shape, that is,
an improved aspect ratio and lower degree of agglomeration, and a
narrower size distribution.A key theme of this paper is using
PAT techniques to gain process
understanding by interpreting the system in terms of nucleation, agglomeration,
and growth behavior (see details in Section ) throughout the crystallization process
by tracking the solute concentration, solute mass, and supersaturation
using UV/vis (the corresponding calibration model is discussed in Section S1). The premise is that product quality
attributes are determined by the trajectory of the crystallization
process within the phase diagram since the kinetics are directly related
to the supersaturation profile;[2] this paper
provides a systematic exploration of the crystallization process,
starting with making simple changes to the order of antisolvent addition/cooling
stages and modifying the seed loading or seeding point to improve
the product quality attributes. These effects alone are not sufficient
to reduce agglomeration in the final product, and therefore more complex
operations, such as wet-milling and feedback-enabled direct nucleation
control, are applied to produce particle growth without further agglomeration.There are different methods to control agglomeration, such as controlling
the supersaturation within the metastable limit,[4] adjusting crystallization trajectories crossing the liquid–liquid
separation region by using a lower solute concentration,[5] applying a bridging liquid to form spherical
agglomeration to improve the size distribution and flowability,[6,7] or changing the pH of the system.[8] In
addition, agglomeration and breakage are competing kinetic processes
that occur simultaneously,[9] so enhancing
breakage is a potential way to reduce agglomeration and control the
product size and shape.[10] Ultrasonic devices
are widely applied in lab-scale experiments to enhance the nucleation
and reduce the agglomeration.[11,12] Similarly, application
of a high-shear rotor–stator wet mill during the crystallization
process is an efficient method to reduce the crystal size,[13] deagglomerate, and manipulate its shape, especially
when needle-shaped crystals are formed.[14,15] Crystal size
reduction is caused by mechanical breakage,[13] and needles are easily fractured to form short crystals and achieve
a more uniform shape distribution.[16] In
this work, the effect of the supersaturation trajectories will be
investigated. The methods of applying a bridging liquid and changing
the pH are not suitable for this API product. Compared with high-shear
stress mechanical devices,[17] ultrasonic
devices are restricted for scale-up.[18] Therefore,
wet milling was investigated as a means to achieve deagglomeration.
There are two widely applied operation modes of a wet mill: (1) operating
the wet mill at the end of the crystallization process,[19] which can lead to production of fines that may
adversely impact filtration, and (2) operating as part of the crystallization
process, either post seeding,[20] inserted
at some point in the process,[21] or at the
end followed by a heat cycle.[22]Undesired
fine crystals generated by wet milling can be dissolved
by subsequent application of temperature cycling, which can be controlled
either via pre-defined (open-loop) temperature cycles[23] or automatically determined via direct nucleation control
(DNC) using closed-loop feedback control.[24] DNC is a model-free feedback control method, which can automatically
implement temperature cycles based on a desired FBRM target count.[25] The effect of different temperature cycles will
be discussed in the results, Sections and 3.3.
Materials and Experimental Methods
Materials
The active pharmaceutical
ingredient (API) applied in this study was compound X supplied by
Takeda, USA (its molecular formula cannot be revealed for commercial
reasons). The crystallization was intended to operate with an initial
solvent volume ratio of methanol (purity of >99.5%, Fisher Chemical)
to antisolvent water (deionized water) of 10/1 (v/v), and the final ratio was 10/6 (v/v). Further product information, such as solubility
curves, were obtained from preliminary experiments. Background information
supplied by Takeda, indicated that two polymorphs can be crystallized
in the methanol–water system: form A (stable, rhombus morphology)
and form L (metastable, needle morphology), which is known to transform
to the more stable form A at room temperature. Form A API was supplied,
as presented in Section S2, which shows
agglomerated crystals with a mean size of d4,3 = 100 μm measured using a Malvern MasterSizer 2000.A sequential antisolvent and cooling strategy was applied in this
work to maximize recovery, so solubility experiments were separated
into two parts: (1) the antisolvent addition process at constant temperature
and (2) the cooling process with a constant solvent volume ratio.
Solutions were prepared with an excess of solid compound X, held at
prescribed values of the temperature and antisolvent ratio and allowed
to equilibrate over 4 h. The solute concentration was obtained by
gravimetric analysis of a filtered sample of the suspension, which
was dried for 36 h in an oven at 40 °C (previously checked to
be sufficient for complete drying; compound X does not form a hydrate
or solvate). The corresponding solubility measurements are presented
in Figure ; each solubility
measurement was repeated three times, and the corresponding error
bars were calculated. The mass-based solubility results were converted
to volume-based results by multiplying by the corresponding density.
The details are presented in Section S3.
Figure 1
Solubility data for compound X: (a) as a function of the water
(antisolvent) ratio of the total volume of the solution at two different
temperatures and (b) as a function of temperature at two different
solvent ratios (some error bars are too small to be visible).
Solubility data for compound X: (a) as a function of the water
(antisolvent) ratio of the total volume of the solution at two different
temperatures and (b) as a function of temperature at two different
solvent ratios (some error bars are too small to be visible).The solubility is more sensitive to changes in
temperature at a
higher ratio of methanol:water and has an order of magnitude-lower
temperature gradient at a ratio of 10/6. This knowledge of the solubility
data can be applied to determine the operating range of each crystallization
step, as discussed in Section .
Experimental Setup
The experimental
rig was built using a batch crystallizer (500 mL) in combination with
a wet mill setup in a recirculation loop, as presented in Figure .
Figure 2
Schematic of the experimental
setup.
Schematic of the experimental
setup.The process temperature in the jacketed glass batch
crystallizer
was measured by a Pt100 thermocouple and controlled with a Huber recirculating
heating/cooling bath (Ministat 125 with Pilot ONE, Huber). PAT tools
were applied to monitor the process variables. A Lasentec D600L focused
beam reflectance measurement (FBRM) probe (Mettler Toledo FBRM iC
software, version 6.7.0) was used to measure the crystal chord length
distribution (CLD) and number of crystals; the measurement time was
set at 10 s. A V918 particle vision and measurement (PVM) probe (Mettler
Toledo PVM image acquisition software, version 8.3), which is a high-resolution
camera, was applied to record in situ crystal images. The solute concentration
was monitored using the intensity of a specific peak in the spectra
(see Section S1) measured by an ATR-UV/vis
probe (MSC621 Carl Zeiss). The UV/vis measurement time was 5 s. All
the process data were collected and controlled in a LabView-based
software, Crystallization Monitoring and Control (CryMOCO).[26] Slurry from the crystallizer was circulated
by a peristaltic pump (P1) at 100 mL/min through an external loop
containing the wet mill (IKA Magic Lab Module ULTRA-TURRAX). Dissipative
heat is generated when the wet mill is operated, which can potentially
dissolve the fine particles; the well mill is jacketed, and a second
Huber was applied to maintain the temperature at the same value as
in the crystallizer.For offline measurements, laser diffraction
(Malvern MasterSizer
2000 with Hydro 2000SM(A)) was used to measure the dried product crystal
size distribution (water was applied as the dispersion solvent; the
dispersion speed was 1500 rpm, and the obscuration range was 10–20%).
Agglomeration was evaluated qualitatively using a microscope (GCT-20
Series Biological microscope, ASPEN). Finally, powder X-ray diffraction
(PXRD) (Bruker D2 Phaser) was used to confirm the polymorphic form
of the product.In the experiments described in Section , it is challenging to interpret
situations
where size multiple-change mechanisms occur, such as growth, agglomeration,
and breakage, which is why multiple sensors have been applied here.
The depletion of the solute mass was monitored by UV/vis and is a
direct indicator of crystal growth; agglomeration and deagglomeration
can be qualitatively observed visually from PVM images and can be
inferred from FBRM counts and chord length distributions; if there
is limited secondary nucleation, then breakage can be inferred from
the FBRM count increase and by the presence of fines in the PVM images.
Baseline Crystallization Experiments
Based on the solubility curves shown in Figure , there is a large decrease in solubility
from the initial point where the solvent volumetric ratio is 10/1
at 55 °C to the end point where the solvent ratio is 10/6 at
20 °C so that a high yield can be achieved. To reduce the complexity
of the operation, a sequential antisolvent–cooling operation
was applied. Two baseline experiments with identical start and end
conditions were investigated to study the effect of the operation
order, as presented in Figure . For both processes, a saturated solution of the API in a
10/1 solvent at 55 °C was seeded and held for approximately 10
min before starting the first antisolvent addition. The order of the
operations in B1 and B2 does not affect the overall yield of the process
(assuming that the crystallization proceeds to equilibrium), but it
does affect the kinetics and trajectory of the crystallization through
the phase diagram.
Figure 3
Two types of sequential antisolvent–cooling baseline
methodologies
B1 and B2.
Two types of sequential antisolvent–cooling baseline
methodologies
B1 and B2.In baseline sequence B1, the cooling process occurs
at the lower
methanol ratio, 10/6, whereas in baseline sequence B2, the cooling
process takes place at a higher methanol ratio, 10/2. The solubility
of the cooling stage in B1 is almost flat (Figure shows a slope of 0.07 mg/(mL K) for the
10/6 solvent mixture in comparison to >0.8 mg/(mL K) at the higher
methanol ratio). Thus, in B2, the supersaturation is mainly generated
in the antisolvent addition stage. If wet milling and temperature
cycling were implemented after the cooling stage of sequence B1, there
will be limited capacity to dissolve the fine particles and grow larger
crystals, which is shown in Section . Based on the trends of the solubility
data shown in Figure , a temperature cycle after the cooling stage of B2 may have the
potential to dissolve more fine particles and improve the product
quality. The details of the corresponding temperature cycling DNC
experiments are discussed in Section .In this work, the final batch volume
was set at 500 mL so that
the initial volume of methanol was 312.5 mL and the volume of water
was 31.25 mL. In experiments using sequences B1 and B2, the antisolvent
addition and cooling rates were kept constant at 1 mL/min and either
0.2 or 0.5 °C/min, respectively.
Results and Discussion
System Understanding
A set of baseline
experiments (Table ) was designed to understand the behavior of the system and especially
to study crystal nucleation, growth, and agglomeration under different
operating conditions.
Table 1
Process Conditions of Baseline Crystallization
Experiments
exp
seeds (g)
type of baseline exp
seeding
point
antisolvent and cooling rate
B1-1
6.87 (23.8%)
B1
t = 0 (10/1, 55 °C)
antisolvent: 1 mL/min;
cooling: 0.2 °C/min for B2-1 and 0.5 °C/min for other B2 experiments
B2-1
6.87 (23.8%)
B2
B2-2
2.4 (9.8%)
B2
B2-3
2.4 (9.8%)
B2
10/2, 55 °C
The % seed loading is defined as the mass of seeds
divided by the
total amount of API (seeds and in solution).Experiments B1-1
and B2-1 were designed to compare the effect of
the sequence of the antisolvent and cooling processes; the effect
of seed loading can be compared using the results of B2-1 and B2-2.
Experiment B2-3 was designed to investigate the effect of adding seeds
later in the sequence, but before, primary nucleation would have occurred.
Effect of Antisolvent and Cooling Order
The process diagrams including FBRM counts, FBRM mean square weighted
chord length (MSWCL), process temperature, solute mass, and UV/vis
measured supersaturation are presented in Figure for experiments B1-1 and B2-1, which investigated
the order of the antisolvent addition and cooling stages. To interpret
the effect of dilution and varying volumes due to the addition of
water (antisolvent), the solute mass in solution is expressed as an
absolute amount of compound X (gram). The supersaturation (S) is calculated from eq , and the data are presented in Figure .where c* is the solubility and c is the solute concentration.
Figure 4
UV/vis
measured solute concentration, calculated supersaturation,
process temperature, FBRM counts, and mean square weighted size for
(a) B1-1 (region 1 = antisolvent addition; region 2 = cooling) and
(b) B2-1 (region 1 = 1st antisolvent addition; region 2 = cooling;
and region 3 = 2nd antisolvent addition).
UV/vis
measured solute concentration, calculated supersaturation,
process temperature, FBRM counts, and mean square weighted size for
(a) B1-1 (region 1 = antisolvent addition; region 2 = cooling) and
(b) B2-1 (region 1 = 1st antisolvent addition; region 2 = cooling;
and region 3 = 2nd antisolvent addition).The calculation of S requires
the solute concentration
from UV/vis and the calibration model (Section S1) along with measurement of the process temperature and application
of the curve-fitted solubility data. When the supersaturation is low, eq shows that the calculation
involves subtraction of two similar numbers, each with an associated
error, and hence the estimated value of S is noisy
(has a large relative error). For clarity of presentation, noise has
been removed from the process variable records using a low-pass filter
(Matlab function “low pass” with a sample time of 1
min and a normalized band-pass frequency of 10–4).In both experiments, the seeds were added at the start and
as expected,
the solute mass decreased during the crystallization process, while
the increase of the supersaturation ratio may be explained by the
decrease of the solubility following antisolvent addition or cooling.For B1-1, the FBRM counts decreased slightly at the beginning of
the first stage (0–40 min during the first antisolvent addition
stage) due to agglomeration and dilution effects caused by the antisolvent
addition. This agglomeration can be seen in the PVM recorded pictures,
presented in Figure a and in Section S5. The supersaturation
ratio at the beginning of region 1 in Figure a increased, and the solute mass in solution
slightly decreased, indicating growth of the seeds, which is consistent
with an increase of the FBRM mean size. The solute mass was very slowly
consumed in region 2 (cooling process), and the FBRM mean size and
counts remained almost constant. The increase of the supersaturation
ratio in region 2 may be explained by reduction of the already very
small values of the solubility during cooling (see Figure b). The absolute supersaturation
was mainly generated in the antisolvent stage (region 1) so that the
effect of the later cooling process is to produce only a small amount
of crystal growth by the generation of limited supersaturation. This
can also be seen by the consumption of the solute mass that decreased
from 21 to 4 g during the antisolvent stage (region 1), compared to
a change of only 3 g in the cooling stage (region 2). The system did
not quite reach the equilibrium state because the holding time was
not long enough at the lowest temperature (the supersaturation ratio
was slightly greater than 0 (500 mL solution) at the end of the experiment).
Figure 5
PVM pictures
at the beginning of the process (after 2 min): (a)
B1-1 and (b) B2-1 indicating agglomeration. Further PVM images for
B1-1 and B2-1 are shown in Section S5.
PVM pictures
at the beginning of the process (after 2 min): (a)
B1-1 and (b) B2-1 indicating agglomeration. Further PVM images for
B1-1 and B2-1 are shown in Section S5.For experiment B2-1, a similar trend was seen in
the first region
(1st antisolvent addition, Figure b) where there was a decrease of the FBRM mean size
and counts, caused by dilution and agglomeration, as shown by the
PVM images (Figure b). In region 2 (cooling process), growth and some secondary nucleation
took place, so the mean size and FBRM counts increased. In region
3 (2nd antisolvent addition), the FBRM mean size increased more rapidly,
and the solute mass fell, indicating growth. The decreasing of the
counts was caused by a combination of dilution (due to the antisolvent
addition) and possibly further agglomeration. The solute mass was
consumed at approximately the same rate during the three stages of
the process: 9 g of the solute mass was consumed during the first
stage (1st antisolvent addition), 12 g during the second stage (cooling),
and 7 g during the third (2nd antisolvent addition). These changes
indicate the relative amounts of crystal growth and secondary nucleation
that occurred at each of these stages.Slightly smaller crystals
were produced in the baseline experiment
B2-1 due to the greater levels of secondary nucleation during the
cooling stage. The final FBRM count of B2-1 is about 2.15 ×104 /s, which is higher than in B1-1, 1.95 ×104 /s. This is consistent with the offline MasterSizer measurements
of the CSD and microscope images presented in Figure a–c.
Figure 6
MasterSizer CSD measurements (a) and microscope
pictures of the
products from experiments of B1-1 (b), B2-1(c), B2-2 (d), and B2-3
(e).
MasterSizer CSD measurements (a) and microscope
pictures of the
products from experiments of B1-1 (b), B2-1(c), B2-2 (d), and B2-3
(e).The volume mean size (d43) for B1-1
was 144 μm, which is only slightly larger than the product size
of 129 μm for B2-1. The volume mean size of the seeds was 100
μm.Overall, the different order of antisolvent and cooling
in B2 did
not provide any substantial improvements (reduced agglomeration and
more uniform CSD) in the product properties as similar mean size crystals
were formed and the product was agglomerated in both cases.
Effect of Seed Loading and Seeding Time
The next set of experiments aimed to study the effect of seed loading
and seed time on the final crystal product qualities. The process
diagram of B2-1 is shown in Figure b, and the results for B2-2 and B2-3 are shown in Figure . The impact of these
process parameters on the supersaturation and FBRM counts is discussed
next and compared to experiment B2-1. The variations of the other
process variables for these experiments are presented in Section S4.
Figure 7
Comparison of experiments B2-1, B2-2,
and B2-3: (a) FBRM counts
and (b) supersaturation (the cooling rate in region 2 is smaller in
B2-1, which is presented as dashed lines). The regions shown are only
for experiments B2-2 and B2-3.
Comparison of experiments B2-1, B2-2,
and B2-3: (a) FBRM counts
and (b) supersaturation (the cooling rate in region 2 is smaller in
B2-1, which is presented as dashed lines). The regions shown are only
for experiments B2-2 and B2-3.Experiment B2-2 was designed to investigate a lower
seed loading
(9.8%) compared with B2-1 (23.8%). The seeds were added at the beginning
of the first stage of antisolvent addition, which was then followed
by the cooling stage (sequence B2 in Figure ). Figure shows that both the supersaturation and FBRM counts
increased continuously in regions 1 and 2 (1st antisolvent addition
and cooling respectively). This indicates slow secondary nucleation
and growth rates that do not fully consume the generated supersaturation
by the end of the cooling process. In B2-2, 5 g of the solute mass
was consumed by the end of stage 2 versus 21 g for B2-1, clearly demonstrating
the impact of a lower seed loading. A rapid nucleation event leading
to a spike in the FBRM counts can be seen at approximately 170 min
(Figure b) during
the second antisolvent addition (region 3). The corresponding PVM
pictures show a noticeable change of crystal habit suggesting that
polymorphic form L was nucleated (Figure ). These needles appear to nucleate in the
high-supersaturation region after the second solvent addition (region
3 on Figure b). The
increase of the supersaturation at the end may be explained by the
slow-growth behavior of both forms A and L.
Figure 8
PVM pictures of B2-2:
(a) seeds, (b) 2 min into the cooling stage
(stage 2), (c) at the beginning of the second antisolvent addition
(stage 3), showing the presence of needles (form L), (d) at the end
of stage 2 (after 200 min), showing high levels of form L.
PVM pictures of B2-2:
(a) seeds, (b) 2 min into the cooling stage
(stage 2), (c) at the beginning of the second antisolvent addition
(stage 3), showing the presence of needles (form L), (d) at the end
of stage 2 (after 200 min), showing high levels of form L.A similar effect was also observed in experiment
B2-3 where seeds
were added at the end of the first antisolvent stage (region 1 in Figure a) and held for 10
min before starting the cooling process (region 2). In the second
antisolvent stage (region 3), the high supersaturation was consumed
resulting in the nucleation and growth of form L crystals, as indicated
by PVM pictures (see Figure ). Again, there is a noticeable change of crystal habit from
the rhombus morphology (form A) to needles (form L). These nucleation
events during the second antisolvent addition produce a large number
of small crystals, as shown by the FBRM data in Figure a.
Figure 9
PVM pictures for experiment B2-3: (a) at the
beginning of the second
antisolvent addition stage where form L nucleated (after 130 min);
(b) at the end of stage 2 (after 200 min), showing high levels of
form L.
PVM pictures for experiment B2-3: (a) at the
beginning of the second
antisolvent addition stage where form L nucleated (after 130 min);
(b) at the end of stage 2 (after 200 min), showing high levels of
form L.With a lower seed loading, mixtures of form A and
form L were produced
at the end of the crystallization process because of the higher levels
of supersaturation generated during the process. However, form L is
shown to undergo a polymorphic transformation to form A at room temperature
within 3 h, as shown by the PVM images in Figure .
Figure 10
PVM pictures as a function of time for experiment
B2-2 during prolonged
aging at room temperature showing polymorph conversion to form A,
which is illustrated by the disappearance of the needles: (a) 300,
(b) 350, (c) 400, and (d) 450 min.
PVM pictures as a function of time for experiment
B2-2 during prolonged
aging at room temperature showing polymorph conversion to form A,
which is illustrated by the disappearance of the needles: (a) 300,
(b) 350, (c) 400, and (d) 450 min.In Figure a, the
CSD of the product crystals from B2-2 and B2-3 are almost overlapping,
which means that the effect of delaying the seed addition point (at S = 0 in B2-2 and at S = 0.28 in B2-3)
has a limited effect on the final product qualities. The dried products
appeared to be agglomerated Form A crystals from both experiments
and fine particles were generated by the transformation of form L
shown in Figure a–d. Therefore, reducing the seed loading does not improve
the crystal product quality.
Conclusions from the Baseline Experiments
The baseline experiments were aimed to gain better understanding
of the behavior of the system in terms of the supersaturation variations
and to reduce the degree of agglomeration by changing the order of
the antisolvent and cooling stages as well as investigating some key
process parameters, namely, seed loading and seeding time. It was
found that the stable form A is characterized by slow nucleation and
growth kinetics, while the metastable form L can be easily nucleated
at high-supersaturation conditions (supersaturation ratio of around
4). In order to control the form and minimize the probability of the
metastable form nucleating, a high seed loading is recommended that
will provide enough surface area to ensure growth-dominated desupersaturation
and maintain an overall low supersaturation; 6.8 g of seed loading
will be applied in subsequent experiments. The rates of consumption
of the solute concentration and hence supersaturations were found
to depend on the order of the cooling and antisolvent stages, which
in turn affect the relative kinetic rates of nucleation versus growth
versus agglomeration, for example, if anti-solvent addition precedes
cooling, high levels of nucleation will be observed. Therefore, all
subsequent experiments will adopt the B2 sequence of steps. Nevertheless,
changes to the anti-solvent addition–cooling sequences and
the seeding conditions did not provide the required improvements in
product quality.The next step was to investigate more complex
operations such as application of wet milling and temperature cycling.
The use of wet milling to induce primary nucleation was investigated,
but this did not improve the required product quality (details are
presented in Section S6). The next section
describes the use of a wet mill as a breakage device to produce deagglomeration
followed by temperature cycling, which was aimed at dissolving fine
particles and producing growth of crystals without reagglomeration.
Pre-defined Temperature Cycle after Wet Milling
The application of wet milling in the crystallization process for
compound X reduced the mean size of the crystals (through a process
of deagglomeration) but generated a large number of fines. The details
of the effects of geometry and rotating speed of the wet mill are
presented in Section S7. To remove fines
from the system, the temperature may be increased so that the solution
becomes undersaturated, resulting in dissolution of the undesired
fine crystals. If nucleation can be controlled, a subsequent cooling
stage will allow the remaining crystals to grow and the mean size
to increase. The details of these experiments are shown in Table .
Table 2
Experiments Using Temperature Cycles
after Wet Millinga
temperature
cycling conditions
exp
baseline methodology
Tmin (°C)
Tmax (°C)
heating rate (°C/min)
cooling rate (°C/min)
DNC set point (#/s)
TC1
B1
20
45
1
0.5
N/A
TC2
B2
20
50
1
0.2
N/A
DNC1
B2
20
50
1 (max)
0.3 (max)
37,000 ± 2000
DNC2
B2
20
50
1 (max)
0.3 (max)
35,000 ±
2000
DNC3
B2
20
50
1 (max)
0.3 (max)
30,000 ± 2000
N/A = not applicable (open loop).
N/A = not applicable (open loop).The initial experiments used pre-determined (open
loop) control
of the heating and cooling steps using the temperature gradients and
ranges specified in Table (TC1 and TC2). The coarse mode rotor–stator with a
rotational speed of 10,000 rpm was applied to reduce the crystal agglomeration,
and the flow rate through the wet mill was set as 100 mL/min. The
experiments for determining the operating parameters are presented
in Section S7. The wet milling was operated
after the cooling process, as shown in the process diagrams in Figure .
Figure 11
UV/vis measured solute
concentration, calculated supersaturation
ratio process temperature, FBRM counts, and mean square weighted size
for (a) TC1 where the negative supersaturation during the wet milling
period was caused by an error in the calibration models; (b) TC2 and
(c) TC2 FBRM counts in chord length regions (μm).
UV/vis measured solute
concentration, calculated supersaturation
ratio process temperature, FBRM counts, and mean square weighted size
for (a) TC1 where the negative supersaturation during the wet milling
period was caused by an error in the calibration models; (b) TC2 and
(c) TC2 FBRM counts in chord length regions (μm).Milling was operated after the baseline sequence
of B1-1 in TC1
(i.e., after anti-solvent addition), and as expected, the number of
crystals immediately increased when the wet mill was started and leveled
off reaching a steady state. The system was then heated from 20 to
45 °C (jacket temperature) at a 1 °C/min rate (the highest temperature of the process (41.5 °C) was lower than 45 °C due to heat loss). The number
of crystals decreased during the heating period, and the mean chord
length increased slightly, indicating that some dissolution had taken
place. Some secondary nucleation occurred during the cooling stage
of the temperature cycle because of the relative high supersaturation
generated and poor growth kinetics of the system. However, the mean
chord length did not change much, further suggesting limited growth.
Furthermore, few crystals were dissolved due to the smaller solubility
change over the range of the temperature cycle that effectively resulted
in around 9% (2.5 g crystals were dissolved compared to ∼28
g of the total solute) of the material being redissolved. Overall,
it may be concluded that the effect of one temperature cycle is limited
after the initial cooling stage in the baseline experiment B1-1.Experiment TC2 employed the conditions of baseline experiment B2-1,
and the wet milling was operated for 50 min at the end of the cooling
stage following the addition of the first portion of antisolvent to
generate a 10/2 ratio of MeOH/H2O. A single open-loop temperature
cycle was then implemented to dissolve the fine particles and redeposit
the mass on the larger crystals. The corresponding process variables
are presented in Figure b. Application of wet milling rapidly increased the FBRM counts
through breakage, but then the fines were agglomerated (as found in
experiments WT2 and WT3 and as presented in Section S7). The solute mass dropped because of the high surface area
available for growth, and the mean chord length increased due to growth
and agglomeration (at around 120 min). This is further evidenced in Figure c: the counts of
the fine crystals (chord length ≤ 50 μm) initially increased
because of the milling and then decreased due to agglomeration. As
expected, the large chord lengths show the opposite trend. During
the heating period (190 min), the fine crystals should dissolve and
the total counts should decrease. Interestingly, the counts were observed
to increase until ∼210 min, possibly as a result of the dissolution
of the weak bridges connecting the fine and large crystals within
the generated agglomerates that resulted in the release of the fine
particles. Therefore, the count of fine particles increased initially
and then decreased during heating (the number of large chord lengths
(large crystals) show the opposite but self-consistent effects in Figure c). Slower secondary
nucleation occurred during the cooling stage of the temperature cycle
(220–370 min), so the FBRM counts slightly increased. The solute
mass fell in this stage, indicating that crystal growth is occurring
as well. At the end of the temperature cycle (∼390 min), the
second antisolvent addition was made and the crystal mean chord length
increased from approximately 80 to 105 μm, which is larger than
the final mean chord length of TC1. Crystal growth in this final stage
is evident since the solute mass continues to fall slowly, resulting
in a build-up of supersaturation.Figure shows
the CSD measurements and microscopy images of the product; there are
fewer fine particles in TC2 compared to TC1, indicating some improvement
in product quality, but the product is still heavily agglomerated.
Therefore, it is recommended to apply the temperature cycle to baseline
experiment B2 to dissolve the fine particles generated by wet milling.
Although the open-loop temperature profile can be pre-defined, it
is not optimal in terms of the number of cycles, which depends on
the maximum/minimum temperature or cooling rates being applied. DNC
is an alternative method that uses feedback control from the FBRM
as a sensor to define the number of temperature cycles based on the
target crystal counts, and this is explored in Section .
Figure 12
MasterSizer measurements
(a) and product microscope images of TC1
(b) and TC2 (c).
MasterSizer measurements
(a) and product microscope images of TC1
(b) and TC2 (c).Many previous studies have discussed the principle
of temperature
cycling to increase Ostwald ripening to remove fines and produce growth
of larger crystals.[27] It is well known
that a single temperature cycle is not sufficient to manipulate the
crystal size[28] or crystal shape.[29] The latter has also shown that the number of
DNC cycles can be reduced by optimal design of the heat and cooling
stages. Neugebauer et al.[30] used 5–25
rapid temperature cycles (feasible in a small-scale tubular crystallizer)
to demonstrate the feasibility of changing the crystal shape by altering
the saturation trajectory alone. Similarly, Simone et al.[31] showed that succinic acid crystals changed shape
from plate- to diamond-like after multiple temperature cycling steps.
DNC Combined with Wet Milling
Direct
nucleation control (DNC) is a model-free feedback control method used
to reduce the width of a CSD, while increasing the mean crystal size.[25,27] The method operates by applying heating and cooling cycles to control
dissolution and nucleation rates to meet a set point, which is commonly
a target number of FBRM counts.[27] Boundaries
are set on either side of the target. When the FBRM count exceeds
the upper boundary, the maximum heating rate is applied; when the
FBRM count is below the lower boundary, the maximum cooling rate is
applied; and between the lower and upper boundaries, the temperature
gradient for heating or cooling is set using proportional control.[25]To apply the DNC, the first step is to
determine the target counts and the boundaries. The counts of TC2
after the temperature cycle was about 4.1 ×104/s,
so the target count of the first trial was set at a lower value of
3.7 ×104±2000/s (DNC1). The boundaries were set
to approximately ±5% (2000/s). The target count was then reduced
to 3.5 ×104± 2000/s (DNC2) and 3.0 ×104± 2000/s (DNC3) to improve product quality. The details
of the experiments are summarized in Table .The corresponding process variables
of each experiment are presented
in Figure . The
start of each experiment follows the operating sequence of TC2; wet
milling is applied with the coarse mode geometry and 10,000 rpm for
approximately 50 min after the end of the cooling stage at a solvent
ratio of 10/2.
Figure 13
UV/vis measured solute concentration, calculated supersaturation,
process temperature, FBRM counts, and mean square weighted size for
(a) DNC, (b) DNC2, and (c) DNC3; (d) FBRM counts in different chord
length ranges (μm) for DNC1 and (e) DNC2.
UV/vis measured solute concentration, calculated supersaturation,
process temperature, FBRM counts, and mean square weighted size for
(a) DNC, (b) DNC2, and (c) DNC3; (d) FBRM counts in different chord
length ranges (μm) for DNC1 and (e) DNC2.Generally, the variation of the counts in DNC1–3
follows
a similar trend to that in TC2 during the milling stage and first
heating cycle where agglomeration and deagglomeration took place (as
described in Section ). To demonstrate that agglomeration occurred in the milling
stage, in DNC1, the system was held at 20 °C for 20
min and the FBRM counts became stable, as shown in Figure a, at around 200 min. The
supersaturation ratio was approximately constant during the same period.
To reduce the agglomeration caused by the wet milling (see Figure d,e), a shorter
milling time (25 min) was applied in DNC3 and the peak in the FBRM
counts at the start of the first heating cycle (compare with DNC1
and DNC2, as presented in Figure d,e) disappeared, indicating that the release of fines
from deagglomeration have been avoided.The number of temperature
cycles increased as the target counts
decreased as it is commonly found; it takes longer to meet a more
difficult target. Three cycles were applied in DNC1 and six cycles
in DNC2 and DNC3 as determined by the feedback control loop. The heating
time of the first heat period becomes longer to dissolve more particles
with the decreased target counts, going from DNC1 to DNC2 and then
DNC3. In some cases, the system is held at the highest temperature
until reaching the target counts. To meet lower target counts and
dissolve more particles, we would require the maximum temperature
to be increased, but then this would take the system close to its
saturation temperature for the starting solution (i.e., there would
be a risk of complete dissolution).All DNC runs were able to
hold the FBRM between the lower and upper
bounds from cycle 1 onward, and there was growth of crystals and an
increase in the mean size as indicated by the decrease of solute mass
and increase of the MSWCL data. As the target counts were reduced,
there was a modest increase in the MSWCL. As expected, the MSWCL was
further increased after the DNC, through the addition of antisolvent
(region 3). Reducing the target counts resulted in shifting the CSD
to larger particle sizes, which is also shown in the offline measurements
depicted in Figure .
Figure 14
(a) MasterSizer measurements and product pictures for (b) DNC1,
(c) DNC2, and (d) DNC3.
(a) MasterSizer measurements and product pictures for (b) DNC1,
(c) DNC2, and (d) DNC3.The degree of agglomeration of product from these
DNC runs is reduced
compared to B2-1 based on the results shown in Figures and b. Due to the properties of the system, some agglomeration
can be observed during the second antisolvent step (region 3) where
the FBRM counts decrease but the mean crystal size increases. Some
agglomeration may be taking place during the filtration and drying
processes, which precede optical microscopy. The benefits of the DNC
approach can be clearly seen from PVM pictures shown in Figure in the case of
DNC2 as an example.
Figure 15
PVM pictures of DNC2: (a) seeds, (b) cooling stage (50
min), (c)
start of milling (160 min), (d) during the milling (210 min), (e)
DNC heating (300 min), (f) DNC cooling (600 min), and (g) final product
(140 min).
PVM pictures of DNC2: (a) seeds, (b) cooling stage (50
min), (c)
start of milling (160 min), (d) during the milling (210 min), (e)
DNC heating (300 min), (f) DNC cooling (600 min), and (g) final product
(140 min).From the PVM images taken at different stages,
the crystals were
agglomerated after the first antisolvent stage and cooling stages
(Figure b). When
wet milling started, agglomerated crystals largely disappeared (Figure c,d) and lots of
fine particles were generated. During the DNC stages, the fine crystals
were gradually dissolved (Figure e), and individual crystals were observed after the
last cooling cycle of the DNC (Figure f). Some agglomeration took place during
the second antisolvent process (Figure g). However, overall, the agglomeration
was reduced by using wet milling embedded within batch sequence B2
followed by feedback-controlled DNC.In this work, DNC was only
applied using heating and cooling to
remove the fine crystals generated by wet milling, although it could
also be applied in the antisolvent stage by switching the addition
of the solvent/antisolvent when the solubility is insensitive to the
temperature.[32] With anti-solvent DNC, considerable
dilution occurs, which can lead to low yields. In addition, supersaturation
control (SSC) can also be applied in the antisolvent stage to maintain
the low supersaturation for crystal growth.[26] The optimized trajectories of antisolvent and temperature profiles
can be simplified as pre-defined set points for guiding the scale-up
process.[32]Scale-up of the improved
process is not considered here. It is
known that (1) wet milling can be directly scaled up based on mechanistic
models of particle breakage[33] and (2) the
time scale for heat transfer increases with the scale of operation;
hence, DNC cycle times become significantly longer, so it becomes
increasingly important to minimize the number of cycles required to
achieve the required product quality.
Conclusions
The sequential antisolvent–cooling
batch crystallization
processes for compound X was studied using PAT tools to monitor the
process variables and allow nucleation, growth, agglomeration, and
breakage to be interpreted from the solute mass and supersaturation
profiles. A UV/vis calibration model was constructed to estimate the
solute concentration (see Section S1),
which allowed supersaturation levels to be calculated throughout the
batch process. FBRM was used to monitor the particle count per second
and give an indication of particle size.The methodology applied
in this paper follows the general workflow
for designing a crystallization process described by Brown et al.[2] but extends it significantly to a more complex
case involving the generation of supersaturation by a combination
of antisolvent addition and cooling. Furthermore, the paper addresses
the complexities of a real API system (Takeda compound X), which exhibits
a strong tendency to agglomerate and forms an undesired polymorph
at high supersaturation ratios; these effects can lead to poor quality
of product crystals, e.g., needles and/or agglomerates with poor filtration,
drying, and flow characteristics. The desired polymorphic form A was
found to have a long induction time (particularly at low supersaturation)
and then exhibit slow growth behavior, which indicated that too rapid
changes in solubility conditions would lead to excessive supersaturation
and undesired product characteristics. The proposed solution to manufacture
improved quality of crystalline products was based on the fundamental
understanding of the trajectory of the process through the phase (or
solubility) diagrams to manipulate the supersaturation time history
and control the relative rates of nucleation, growth, and agglomeration
while avoiding the high supersaturations (by adding a higher seed
loading), which lead to this undesired polymorphic transformation.
It is shown that the solubility data are key to understanding this
process and were used to propose better sequences of operations and
improved seeding conditions, but this still was not sufficient to
reduce agglomeration in the final product. The use of a wet mill gives
an additional degree of freedom to break any agglomerates that have
formed but has the disadvantage of producing a wide CSD with an excessive
number of fine particles, which can reagglomerate and detract from
the final product quality. Open-loop temperature cycling shows limited
improvement in terms of removal of fines, but the process is not easily
optimized and does not adapt to current conditions in the crystallizer.
However, use of a closed feedback loop of DNC cycles based on a pre-determined
FBRM target count may be more effective to remove fines by selective
dissolution and grow larger particles without encountering further
agglomeration. Thus, with redesign of the process, the product shows
a much lower degree of agglomeration when manufactured using the improved
sequence of antisolvent addition and cooling followed by a period
of wet milling for deagglomeration and finally application of DNC
to achieve a high yield of large single crystals of the desired polymorph.
Authors: Yang Yang; Kanjakha Pal; Andy Koswara; Qingqing Sun; Yuqi Zhang; Justin Quon; Rahn McKeown; Charles Goss; Zoltan K Nagy Journal: Int J Pharm Date: 2017-09-19 Impact factor: 5.875
Authors: Peter Neugebauer; Javier Cardona; Maximilian O Besenhard; Anna Peter; Heidrun Gruber-Woelfler; Christos Tachtatzis; Alison Cleary; Ivan Andonovic; Jan Sefcik; Johannes G Khinast Journal: Cryst Growth Des Date: 2018-06-15 Impact factor: 4.076